Atenção: Todas as denúncias são sigilosas e sua identidade será preservada.
Os campos nome e e-mail são de preenchimento opcional
Metadados | Descrição | Idioma |
---|---|---|
Autor(es): dc.contributor | Irvine | - |
Autor(es): dc.contributor | Universidade Estadual Paulista (Unesp) | - |
Autor(es): dc.creator | Sharma, Ajay N. | - |
Autor(es): dc.creator | Michelle, Lauren | - |
Autor(es): dc.creator | Juhasz, Margit | - |
Autor(es): dc.creator | Muller Ramos, Paulo [UNESP] | - |
Autor(es): dc.creator | Atanaskova Mesinkovska, Natasha | - |
Data de aceite: dc.date.accessioned | 2022-02-22T00:26:03Z | - |
Data de disponibilização: dc.date.available | 2022-02-22T00:26:03Z | - |
Data de envio: dc.date.issued | 2020-12-11 | - |
Data de envio: dc.date.issued | 2020-12-11 | - |
Data de envio: dc.date.issued | 2020-08-01 | - |
Fonte completa do material: dc.identifier | http://dx.doi.org/10.1111/ijd.14933 | - |
Fonte completa do material: dc.identifier | http://hdl.handle.net/11449/198961 | - |
Fonte: dc.identifier.uri | http://educapes.capes.gov.br/handle/11449/198961 | - |
Descrição: dc.description | Background: Topical minoxidil has been used for almost 40 years to treat alopecia. There is growing evidence supporting off-label use of low-dose oral minoxidil. Objective: To conduct a systematic review evaluating the use of oral minoxidil for all types of alopecia. Methods: A primary literature search was conducted using PubMed in May 2019, utilizing the search term “oral minoxidil AND (hair loss OR alopecia OR baldness)”. Reviews, non-English studies, and articles concerning only topical minoxidil were excluded. Results: Ten articles were included for review comprising a total 19,218 patients (215 women and 19,003 men). Oral minoxidil dose ranged from 0.25 to 5 mg daily to twice daily. The strongest evidence existed for androgenetic alopecia and alopecia areata (AA), with 61–100% and 18–82.4% of patients demonstrating objective clinical improvement. Successful treatment of female pattern hair loss, chronic telogen effluvium, monilethrix, and permanent chemotherapy-induced alopecia was also reported. The most common adverse effects with oral minoxidil included hypertrichosis and postural hypotension. Conclusion: Oral minoxidil is a safe and successful treatment of androgenic alopecia and AA. In addition to its therapeutic benefits, practical advantages over topical minoxidil stem from improved patient compliance. | - |
Descrição: dc.description | Department of Dermatology University of California Irvine | - |
Descrição: dc.description | São Paulo State University – UNESP | - |
Descrição: dc.description | São Paulo State University – UNESP | - |
Formato: dc.format | 1013-1019 | - |
Idioma: dc.language | en | - |
Relação: dc.relation | International Journal of Dermatology | - |
???dc.source???: dc.source | Scopus | - |
Título: dc.title | Low-dose oral minoxidil as treatment for non-scarring alopecia: a systematic review | - |
Tipo de arquivo: dc.type | livro digital | - |
Aparece nas coleções: | Repositório Institucional - Unesp |
O Portal eduCAPES é oferecido ao usuário, condicionado à aceitação dos termos, condições e avisos contidos aqui e sem modificações. A CAPES poderá modificar o conteúdo ou formato deste site ou acabar com a sua operação ou suas ferramentas a seu critério único e sem aviso prévio. Ao acessar este portal, você, usuário pessoa física ou jurídica, se declara compreender e aceitar as condições aqui estabelecidas, da seguinte forma: